Business Daily.
.
A+ R A-

ArcherDX Launches VariantPlex™ p53 Panel for Targeted NGS

E-mail Print PDF
BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX launches the Archer VariantPlex p53 Panel, a targeted NGS-based assay to detect germline and somatic mutations of the TP53 gene, which is frequently mutated in cancer.

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media